| |
| |
|
| Insider
Information: |
Mahony Susan |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
40,685 |
|
|
Indirect Shares
|
18,339 |
|
|
| Direct
Value |
$33,840,156 |
|
|
|
Indirect Value
|
$15,253,647 |
|
|
| Total
Shares |
59,024 |
|
|
| Total
Value |
$49,093,802 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
SVP & Pres., Lilly Onc... |
2018-04-16 |
40,685 |
2018-04-16 |
18,339 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
Senior VP, Human ResourcesOffi |
• – – |
2009-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,534 |
|
- |
|
| LLY |
Eli Lilly & Co |
Senior VP, Human ResourcesOffi |
• – – |
2009-05-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
531 |
|
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2013-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,943 |
57,380 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP, Human Resources |
• – – |
2013-11-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,056 |
47,936 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2014-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,107 |
89,425 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2014-07-28 |
4 |
OE |
$0.00 |
$0 |
I/I |
2,240 |
9,875 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2014-12-04 |
5 |
GD |
$0.00 |
$0 |
D/D |
730 |
86,757 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2015-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,591 |
93,408 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2015-03-04 |
5 |
GD |
$0.00 |
$0 |
D/D |
140 |
62,588 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2015-11-06 |
5 |
GD |
$0.00 |
$0 |
I/I |
600 |
8,384 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,843 |
91,524 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2016-12-01 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,584 |
14,117 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2016-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
737 |
67,065 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,732 |
96,040 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2017-11-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,861 |
39,024 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
• – – |
2018-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,326 |
60,350 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-05-02 |
4 |
OE |
$0.00 |
$0 |
I/I |
12,036 |
12,036 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
18,409 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2022-04-29 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,223 |
18,275 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,913 |
3,913 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP, HR & Diversity |
• – – |
2011-01-25 |
4 |
A |
$34.73 |
$322,885 |
D/D |
9,297 |
27,543 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP, HR & Diversity |
• – – |
2011-01-25 |
4 |
A |
$34.73 |
$60,083 |
I/I |
1,730 |
3,276 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-05-02 |
4 |
D |
$35.62 |
$168,305 |
I/I |
(4,725) |
7,311 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP, Human Resources |
• – – |
2010-01-26 |
4 |
A |
$36.16 |
$315,026 |
D/D |
8,712 |
18,246 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Senior VP, Human Resources |
• – – |
2010-01-26 |
4 |
A |
$36.16 |
$55,903 |
I/I |
1,546 |
1,546 |
0 |
- |
|
70 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
